Lorazepam xanax
Pro Research Analysisby 
Searched over 200M research papers for "lorazepam xanax"
Comparative Analysis of Lorazepam and Xanax
Introduction to Lorazepam and Xanax
Lorazepam (Temesta) and alprazolam (Xanax) are two commonly prescribed benzodiazepines known for their anxiolytic properties. These medications are frequently used to manage anxiety disorders and other related conditions due to their effectiveness in reducing anxiety symptoms2.
Psychomotor Effects of Lorazepam and Xanax
Reaction Times and Cognitive Performance
A study investigated the effects of single oral doses of lorazepam (2.5 mg) and alprazolam (0.5 mg) on psychomotor functions, specifically focusing on reaction times in young healthy volunteers. The study utilized a double-blind cross-over design to assess the impact of these drugs on a choice reaction time test involving visual stimuli1.
The findings revealed that lorazepam significantly prolonged reaction times compared to a placebo, indicating a notable impairment in psychomotor performance. In contrast, alprazolam did not show a significant effect on reaction times, suggesting a lesser impact on cognitive functions in this context1.
Influence of Stimulus Presentation and Warning Signals
The study also explored how different experimental conditions, such as varying stimulus presentation rates and the presence of warning signals, affected performance. It was observed that increasing the interstimulus interval led to a uniform increase in reaction times across all conditions. However, the introduction of a warning signal improved performance in all conditions, with a more pronounced improvement noted after lorazepam intake compared to the placebo. This suggests that while lorazepam impairs baseline performance, the presence of a warning signal can partially mitigate this effect1.
Clinical Use and Safety Profile
Usage and Prescription Trends
Lorazepam and alprazolam are among the top 100 prescribed medications, reflecting their widespread use in clinical practice. They are utilized for various clinical situations, including anxiety disorders, panic disorders, and other related conditions2.
Safety and Dependence Concerns
Benzodiazepines, including lorazepam and alprazolam, are generally considered safer than barbiturates, particularly concerning respiratory depression, which is significantly less with benzodiazepines. Consequently, they are rarely lethal in overdose situations. However, chronic use of benzodiazepines can lead to addiction, raising concerns about potential abuse and dependence among patients. This necessitates careful monitoring and consideration by prescribers to mitigate these risks2.
Conclusion
In summary, lorazepam and alprazolam are effective anxiolytic medications with distinct impacts on psychomotor functions. Lorazepam significantly impairs reaction times, while alprazolam has a lesser effect in this regard. Both medications are widely prescribed and generally safe, though they carry risks of addiction with long-term use. Understanding these differences and potential risks is crucial for optimizing their clinical use and ensuring patient safety.
Sources and full results
Most relevant research papers on this topic
The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.
Lorazepam significantly prolonged reaction times in young healthy volunteers, while alprazolam did not, with warning signals improving performance more pronounced after lorazepam.
RCTDrug use review.
BZDs are commonly prescribed for various clinical situations, but chronic use can lead to addiction and prescribers worry about liability for abuse and dependence.
Psychotropic drugs in the elderly. Selection of the appropriate agent.
Select short-half-life benzodiazepines for elderly patients, and use caution with antipsychotics and tricyclic antidepressants.
Lorazepam, a new benzodiazepine derivative, in the treatment of anxiety: a double-blind clinical evaluation.
Lorazepam effectively relieves moderate to severe anxiety with no serious adverse effects or interactions with other medications.
RCTAdverse performance effects of acute lorazepam administration in elderly long-term users: Pharmacokinetic and clinical predictors
Acute lorazepam administration in elderly long-term users leads to reduced recall and psychomotor slowing, highlighting the importance of cognitive toxicity in benzodiazepine use.
RCTLorazepam: a randomized, double-blind, crossover study of a new antiemetic in patients receiving cytotoxic chemotherapy and prochlorperazine.
Lorazepam effectively reduces nausea and vomiting in patients receiving cytotoxic chemotherapy, making it a useful adjunct to prochlorperazine for controlling these symptoms.
RCTTreatment of Agitation With Lorazepam in Clinical Practice: A Systematic Review
Lorazepam is a clinically effective treatment for acute agitation in patients with mental and behavioral disorders, with dizziness, sedation, and somnolence being common adverse events.
Systematic ReviewContinuum of Care of Clonazepam Misuse Prescription in Mental Health Psychiatry Outpatient Clinics: A Project from K.S.A
Clonazepam misuse in mental health psychiatry outpatient clinics is associated with a number of risks, most worrisome being the potential for physical dependence, even when using the drug as instructed.
Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
Lorazepam significantly improves anxiety symptoms associated with chronic enteritis and ulcerative colitis compared to placebo, with infrequent side effects.
RCTLorazepam: A Review of its Clinical
Lorazepam is a well-studied sedative, antianxiety, and hypnotic agent with similar efficacy and tolerability to diazepam, but has a slower onset of action and longer duration of action.
Literature Review